Direkt zum Inhalt
Merck
  • Second messengers mediating the proliferation and collagen synthesis of tenocytes induced by low-level laser irradiation.

Second messengers mediating the proliferation and collagen synthesis of tenocytes induced by low-level laser irradiation.

Lasers in medical science (2014-09-19)
Mei-Hsiu Chen, Yun-Chien Huang, Jui-Sheng Sun, Yuan-Hung Chao, Ming-Hong Chen
ZUSAMMENFASSUNG

For decades, low-level laser therapy (LLLT) has widespread applications in tendon-related injuries. Although the therapeutic effect of LLLT could be explained by photostimulation of target tissue and cells, how tenocytes sense photonic energy and convert them into cascades of cellular and molecular events is still not well understood. This study was designed to elucidate the effects of LLLT on cell proliferation and collagen synthesis by examining the associated second messengers including ATP, Ca(2+), and nitric oxide using rat Achilles tenocytes. Moreover, proliferating cell nuclear antigen (PCNA) and transforming growth factor-β1 (TGF-β1) related to cell proliferation and matrix metabolism were also studied. The results showed that 904 nm GaAs laser of 1 J/cm(2) could significantly increase the MTT activity and collagen synthesis of tenocytes. Second messengers including ATP and intracellular Ca2+ were increased after laser treatment. Quantitative PCR analysis of tenocytes treated with laser revealed up-regulated expression of PCNA, type I collagen, and TGF-β1. Besides, laser-induced TGF-β1 expression was significantly inhibited by extracellular signal-regulated kinase (ERK) specific inhibitor (PD98059). The findings suggested that LLLT stimulated ATP production and increased intracellular calcium concentration. Directly or indirectly via production of TGF-β1, these second messengers mediated the proliferation of tenocytes and synthesis of collagen.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Ethylendiamin, purified by redistillation, ≥99.5%
Sigma-Aldrich
Ethylendiamin, ReagentPlus®, ≥99%
Sigma-Aldrich
Sulfanilamid, ≥98%
Sigma-Aldrich
Ethylendiamin, BioXtra
USP
Sulfanilamid, United States Pharmacopeia (USP) Reference Standard
USP
Sulfanilamid, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Ethylendiamin -Lösung, technical, 75-80%
Sigma-Aldrich
Ethylendiamin, puriss. p.a., absolute, ≥99.5% (GC)
Sigma-Aldrich
Sulfanilamid, puriss. p.a., ≥98% (calc. to the dried substance)
Supelco
Sulfanilamid Schmelzpunktstandard, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Ethylendiamin, analytical standard
Supelco
Sulfanilamid, VETRANAL®, analytical standard
Sigma-Aldrich
Ethylendiamin, meets USP testing specifications
Sulfanilamid, European Pharmacopoeia (EP) Reference Standard